Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Effects of empagliflozin on functional capacity, LV filling pressure, and cardiac reserves in patients with type 2 diabetes mellitus and heart failure with preserved ejection fraction: a randomized controlled open-label trial

Fig. 3

Individual and mean changes from baseline (95% CI) in the left atrial volume index (LAVI, a), pulmonary artery systolic pressure (PASP, b), annulus relaxation velocity (e′, c), and tricuspid annular plane systolic excursion (TAPSE, d) in both study groups. Individual changes are represented by circles, the squares indicate the means, and the error bars indicate the 95% CIs

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840